Epidermal growth factor receptor (EGFR) is expressed in 50% of NSCLCs, and its expression is correlated with poor prognosis. These two factors make EGFR and its family members prime candidates for ...

肺癌的主要亚型非小细胞肺腺癌有比较大的概率可以靶向治疗，对于亚裔的非小细胞肺腺癌患者来说，EGFR基因突变概率非常高，可以达到50%的突变 ...

This row represents the cycle course in which adverse events started ... in patients with advanced solid tumors, known to express EGFR/HER2, who had progressed following prior standard therapies.

During a Case-Based Roundtable® event, Joshua K. Sabari, MD, continued discussion of key outcomes from the MARIPOSA trial and ...